Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by McRambuson Mar 16, 2019 2:29pm
71 Views
Post# 29496113

RE:RE:RE:RE:RE:RE:Meir Wins in Any Comparison

RE:RE:RE:RE:RE:RE:Meir Wins in Any Comparison
JohnnyUtah16 wrote: Such an angry simpleton. So you bought at the high ($10.74 not $11) and the current share price is $8.01 not $7.30 (stretching numbers to make the drop sound more extreme), just means you are a dumba$$. Man its actually pretty hard to buy at the absolute peak of a companies share price yet you did it, thats a special talent. Like riding the short bus special. Its all about perspective. Most of the rest of us were buying the $7.60 to $8 range over the last few months as we saw the consolidation and stong floor so we are slightly up/even/or slightly down. Don't assume others are as bad at this as you are.


You didn't answer the question, how many more dummies did your mother make besides you? You can at least get your facts straight before making a total fool of yourself. High of the stock is $11.03 and as of 3:45 yesterday it was at a near 3 year low at $7.35. I don't care what your cost basis is, stop posting lies you've embarrased yourself enough already.
Bullboard Posts